Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases

Published:2023-08-03 Issue:8 Volume:20 Page:1085-1095
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Matera Maria Gabriella¹,Calzetta Luigino²,Rinaldi Barbara¹,Cazzola Mario³^ORCID,Rogliani Paola³^ORCID

Affiliation:

1. Unit of Pharmacology, Department of Experimental Medicine, University of Campania ‘Luigi Vanvitelli’, Naples, Italy

2. Unit of Respiratory Diseases and Lung Function, Department of Medicine and Surgery, University of Parma, Parma, Italy

3. Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome ‘Tor Vergata’, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2023.2260310

Reference101 articles.

1. Severe Asthma and Biological Therapy: When, Which, and for Whom

2. Biologic therapies for chronic obstructive pulmonary disease

3. Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

4. Monoclonal antibodies for the treatment of squamous cell carcinoma: A literature review

5. Recently approved and emerging monoclonal antibody immune checkpoint inhibitors for the treatment of advanced non-small cell lung cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma;Expert Opinion on Pharmacotherapy;2024-07-23

2. Biologics, theranostics, and personalized medicine in drug delivery systems;Pharmacological Research;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3